Literature DB >> 5353531

Acetoacetylation of insulin.

D G Lindsay, S Shall.   

Abstract

Insulin was treated with diketen at pH6.9. The reaction mixture was resolved into four components by DEAE-Sephadex chromatography. The first component was unchanged insulin. The second and third components were shown by end-group analysis to be substituted on phenylalanine B-1 and glycine A-1 respectively. The fourth component was disubstituted on both phenylalanine B-1 and glycine A-1. The in-amino group of lysine B-29 was not involved in the reaction at low reagent concentrations. The purity of these derivatives was checked by their electrophoretic behaviour and by measurement of the rate of their reaction with trinitrobenzenesulphonic acid. The hormonal activity of the derivatives was determined. The effect of the modifications on the hormonal activity and the tertiary structure of insulin is discussed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5353531      PMCID: PMC1185142          DOI: 10.1042/bj1150587

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Preparation and properties of fluorescent insulin derivatives.

Authors:  F TIETZE; G E MORTIMORE; N R LOMAX
Journal:  Biochim Biophys Acta       Date:  1962-05-21

2.  The labile amide in insulin: preparation of desalanine-desamido-insulin.

Authors:  L I SLOBIN; F H CARPENTER
Journal:  Biochemistry       Date:  1963 Jan-Feb       Impact factor: 3.162

3.  Preparation and properties of dinitrophenyl-NH(epsilon)-insulin.

Authors:  C H LI
Journal:  Nature       Date:  1956-12-22       Impact factor: 49.962

4.  Acetyl chymotrypsin and its reaction with ethanol.

Authors:  A K BALLS; H N WOOD
Journal:  J Biol Chem       Date:  1956-03       Impact factor: 5.157

5.  A modified ninhydrin reagent for the photometric determination of amino acids and related compounds.

Authors:  S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

6.  The essential groups of insulin.

Authors:  J FRAENKEL-CONRAT; H FRAENKEL-CONRAT
Journal:  Biochim Biophys Acta       Date:  1950-03

7.  Reversible acetoacetylation of amino groups in proteins .

Authors:  A Marzotto; P Pajetta; L Galzigna; E Scoffone
Journal:  Biochim Biophys Acta       Date:  1968-04-09

8.  The reaction of 2,4,6-trinitrobenzenesulphonic acid with amino acids, Peptides and proteins.

Authors:  R B Freedman; G K Radda
Journal:  Biochem J       Date:  1968-07       Impact factor: 3.857

9.  Preparation and characterization of desoctapeptide-insulin.

Authors:  W W Bromer; R E Chance
Journal:  Biochim Biophys Acta       Date:  1967-02-21

10.  A kinetic study of the reactions of amino acids and peptides with trinitrobenzenesulfonic acid.

Authors:  A R Goldfarb
Journal:  Biochemistry       Date:  1966-08       Impact factor: 3.162

View more
  5 in total

1.  Synthesis of palmitoyl derivatives of insulin and their biological activities.

Authors:  M Hashimoto; K Takada; Y Kiso; S Muranishi
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

2.  Radioimmunoassay of chemically modified insulins.

Authors:  D I Dron; R H Jones; P H Sönksen; J H Thomas; D Brandenburg
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

3.  The relation of polypeptide hormone structure and flexibility to receptor binding: the relevance of X-ray studies on insulins, glucagon and human placental lactogen.

Authors:  R A Pullen; J A Jenkins; I J Tickle; S P Wood; T L Blundell
Journal:  Mol Cell Biochem       Date:  1975-07-31       Impact factor: 3.396

4.  Stability of acyl derivatives of insulin in the small intestine: relative importance of insulin association characteristics in aqueous solution.

Authors:  H Asada; T Douen; Y Mizokoshi; T Fujita; M Murakami; A Yamamoto; S Muranishi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

5.  The acetylation of insulin.

Authors:  D G Lindsay; S Shall
Journal:  Biochem J       Date:  1971-03       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.